Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL.

Degterev A, Lugovskoy A, Cardone M, Mulley B, Wagner G, Mitchison T, Yuan J.

Nat Cell Biol. 2001 Feb;3(2):173-82.

PMID:
11175750
2.
3.

Mitochondrial membrane permeabilisation by Bax/Bak.

Degli Esposti M, Dive C.

Biochem Biophys Res Commun. 2003 May 9;304(3):455-61. Review.

PMID:
12729579
4.

How the Bcl-2 family of proteins interact to regulate apoptosis.

van Delft MF, Huang DC.

Cell Res. 2006 Feb;16(2):203-13. Review.

5.
6.

Structural biology of the Bcl-2 family of proteins.

Petros AM, Olejniczak ET, Fesik SW.

Biochim Biophys Acta. 2004 Mar 1;1644(2-3):83-94. Review.

7.

Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis?

Vander Heiden MG, Thompson CB.

Nat Cell Biol. 1999 Dec;1(8):E209-16. Review.

PMID:
10587660
8.

Bcl-2-family proteins: the role of the BH3 domain in apoptosis.

Kelekar A, Thompson CB.

Trends Cell Biol. 1998 Aug;8(8):324-30. Review.

PMID:
9704409
9.

BH3-only proteins: a 20-year stock-take.

Doerflinger M, Glab JA, Puthalakath H.

FEBS J. 2015 Mar;282(6):1006-16. doi: 10.1111/febs.13190. Epub 2015 Jan 26. Review.

10.

The Bcl-2 protein family.

Antonsson B, Martinou JC.

Exp Cell Res. 2000 Apr 10;256(1):50-7. Review. No abstract available.

PMID:
10739651
11.

BH3-Only proteins-essential initiators of apoptotic cell death.

Huang DC, Strasser A.

Cell. 2000 Dec 8;103(6):839-42. Review. No abstract available.

12.

Intracellular mechanisms of ovarian cell apoptosis.

Hsu SY, Hsueh AJ.

Mol Cell Endocrinol. 1998 Oct 25;145(1-2):21-5. Review.

PMID:
9922095
13.

Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside.

Vela L, Marzo I.

Curr Opin Pharmacol. 2015 Aug;23:74-81. doi: 10.1016/j.coph.2015.05.014. Epub 2015 Jun 14. Review.

PMID:
26079328
14.

Mitochondria and apoptosis: new therapeutic targets.

Hockenbery DM, Giedt CD, O'Neill JW, Manion MK, Banker DE.

Adv Cancer Res. 2002;85:203-42. Review. No abstract available.

PMID:
12374287
15.

BCL-2 family: regulators of cell death.

Chao DT, Korsmeyer SJ.

Annu Rev Immunol. 1998;16:395-419. Review.

PMID:
9597135
16.

Functions of the C-terminal domains of apoptosis-related proteins of the Bcl-2 family.

Gómez-Fernández JC.

Chem Phys Lipids. 2014 Oct;183:77-90. doi: 10.1016/j.chemphyslip.2014.05.003. Epub 2014 Jun 2. Review.

PMID:
24892727
17.

BNips: a group of pro-apoptotic proteins in the Bcl-2 family.

Zhang HM, Cheung P, Yanagawa B, McManus BM, Yang DC.

Apoptosis. 2003 Jun;8(3):229-36. Review.

PMID:
12766483
18.

Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.

Rong YP, Barr P, Yee VC, Distelhorst CW.

Biochim Biophys Acta. 2009 Jun;1793(6):971-8. doi: 10.1016/j.bbamcr.2008.10.015. Epub 2008 Nov 12. Review.

19.

Intrinsically disordered proteins in bcl-2 regulated apoptosis.

Rautureau GJ, Day CL, Hinds MG.

Int J Mol Sci. 2010 Apr 16;11(4):1808-24. doi: 10.3390/ijms11041808. Review.

20.

Therapeutic modulation of apoptosis: targeting the BCL-2 family at the interface of the mitochondrial membrane.

Nemec KN, Khaled AR.

Yonsei Med J. 2008 Oct 31;49(5):689-97. doi: 10.3349/ymj.2008.49.5.689. Review.

Supplemental Content

Support Center